nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma
|
Yazbeck, Victor |
|
2018 |
18 |
9 |
p. 569-575.e1 |
artikel |
2 |
Bone Health and Survival in Women With Multiple Myeloma
|
Rosko, Ashley E. |
|
2018 |
18 |
9 |
p. 597-602.e1 |
artikel |
3 |
Editorial Board
|
|
|
2018 |
18 |
9 |
p. A4-A5 |
artikel |
4 |
Hodgkin Lymphoma With Multiple Autoimmune Disorders: Case Report and Review of the Literature
|
Grover, Natalie S. |
|
2018 |
18 |
9 |
p. e365-e368 |
artikel |
5 |
Hypomethylating Agents-associated Infections—Systematic Review and Meta-analysis of Randomized Controlled Trials
|
Shargian-Alon, Liat |
|
2018 |
18 |
9 |
p. 603-610.e1 |
artikel |
6 |
Identifying Tyrosine Kinase Inhibitor Nonadherence in Chronic Myeloid Leukemia: Subanalysis of TAKE-IT Pilot Study
|
Leader, Avi |
|
2018 |
18 |
9 |
p. e351-e362 |
artikel |
7 |
Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis
|
Lee, Yen-Chien |
|
2018 |
18 |
9 |
p. 558-568 |
artikel |
8 |
Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment
|
Malecek, Mary-Kate |
|
2018 |
18 |
9 |
p. e363-e364 |
artikel |
9 |
Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States
|
Mesa, Ruben |
|
2018 |
18 |
9 |
p. 590-596 |
artikel |
10 |
Prevalence of Monoclonal Gammopathy of Undetermined Significance in India—A Hospital-based Study
|
Gupta, Ritu |
|
2018 |
18 |
9 |
p. e345-e350 |
artikel |
11 |
Sustained Remission of γδ T-Cell Lymphoma by Graft-Versus-Lymphoma Effect That Relapsed Early After Cord Blood Transplantation
|
Ichikawa, Satoshi |
|
2018 |
18 |
9 |
p. e369-e372 |
artikel |
12 |
Table of Contents
|
|
|
2018 |
18 |
9 |
p. A6, A12-A13 |
artikel |
13 |
The Multiple Myeloma Drug Pipeline—2018: A Review of Small Molecules and Their Therapeutic Targets
|
Abramson, Hanley N. |
|
2018 |
18 |
9 |
p. 611-627 |
artikel |
14 |
Treatment of Older Patients With Newly Diagnosed AML Unfit for Traditional Therapy
|
Burnett, Alan K. |
|
2018 |
18 |
9 |
p. 553-557 |
artikel |
15 |
Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma
|
Kumar, Vivek |
|
2018 |
18 |
9 |
p. 576-589.e1 |
artikel |
16 |
Venetoclax in Combination With Bortezomib, Dexamethasone, and Daratumumab for Multiple Myeloma
|
Rahbari, Kian J. |
|
2018 |
18 |
9 |
p. e339-e343 |
artikel |